ICD-10-CM Billable Code

C69.12

Malignant neoplasm of left cornea

Clinical Classification Guidelines

Medical Intelligence & Overview

Malignant neoplasm of the left cornea, classified under ICD-10 code C69.12, is a rare form of eye cancer that affects the transparent front part of the eye known as the cornea. This condition involves abnormal, uncontrolled growth of malignant cells in the cornea's tissue. Early detection and treatment are essential to prevent the spread of the disease and preserve visual function.

Causes & Symptoms

Clinical Causes: Exposure to certain ultraviolet (UV) light radiation Long-term exposure to carcinogenic chemicals or substances History of eye trauma or injury Chronic inflammatory conditions of the eye Previous radiation therapy to the eye area Genetic predisposition and family history of ocular cancers Compromised immune system due to illness or immunosuppressive therapy

Key Symptoms: Persistent eye redness or irritation Unusual growth or thickening of the corneal tissue Blurred or decreased vision in the affected eye Presence of a visible painless mass on the cornea Sensitivity to light (photophobia) Eye discomfort or a foreign body sensation Sudden appearance of a pigmented or non-pigmented lesion

Diagnostic & Treatment

Diagnosis Path: Corneal biopsy to obtain tissue samples for histopathological analysis Imaging tests such as ocular ultrasound or anterior segment optical coherence tomography (AS-OCT) Fundus examination to rule out intraocular extension or metastasis Assessment of the patient's medical and ocular history to identify risk factors

Treatment Protocols: Surgical excision or removal of the tumor via local resection Cryotherapy to freeze and destroy malignant cells Laser therapy, such as Phototherapeutic Keratectomy (PTK), to ablate abnormal tissue In cases of extensive or invasive tumors, partial or total corneal transplantation may be necessary Radiation therapy, including plaque brachytherapy, to target malignant tissues Adjunctive use of topical chemotherapeutic agents like mitomycin C Close follow-up and regular monitoring for recurrence or metastasis

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is C69.12 a billable ICD-10 code?
Yes, C69.12 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report C69.12?
Clinical documentation must specify the nature of Malignant neoplasm of left cornea and any associated comorbidities for accurate reporting.

Cite this Clinical Reference